|
|
(One intermediate revision not shown.) |
Line 1: |
Line 1: |
| | | |
| ==NMR STRUCTURE OF DES[GLY1]-CONTRYPHAN-R CYCLIC PEPTIDE (MAJOR FORM)== | | ==NMR STRUCTURE OF DES[GLY1]-CONTRYPHAN-R CYCLIC PEPTIDE (MAJOR FORM)== |
- | <StructureSection load='1dg0' size='340' side='right'caption='[[1dg0]], [[NMR_Ensembles_of_Models | 20 NMR models]]' scene=''> | + | <StructureSection load='1dg0' size='340' side='right'caption='[[1dg0]]' scene=''> |
| == Structural highlights == | | == Structural highlights == |
| <table><tr><td colspan='2'>[[1dg0]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Conus_radiatus Conus radiatus]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1DG0 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1DG0 FirstGlance]. <br> | | <table><tr><td colspan='2'>[[1dg0]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Conus_radiatus Conus radiatus]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1DG0 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1DG0 FirstGlance]. <br> |
- | </td></tr><tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=CY3:2-AMINO-3-MERCAPTO-PROPIONAMIDE'>CY3</scene>, <scene name='pdbligand=DTR:D-TRYPTOPHAN'>DTR</scene>, <scene name='pdbligand=HYP:4-HYDROXYPROLINE'>HYP</scene></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR, 20 models</td></tr> |
- | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat"><div style='overflow: auto; max-height: 3em;'>[[1qfb|1qfb]], [[1dfy|1dfy]], [[1dfz|1dfz]]</div></td></tr>
| + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CY3:2-AMINO-3-MERCAPTO-PROPIONAMIDE'>CY3</scene>, <scene name='pdbligand=DTR:D-TRYPTOPHAN'>DTR</scene>, <scene name='pdbligand=HYP:4-HYDROXYPROLINE'>HYP</scene></td></tr> |
| <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1dg0 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1dg0 OCA], [https://pdbe.org/1dg0 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1dg0 RCSB], [https://www.ebi.ac.uk/pdbsum/1dg0 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1dg0 ProSAT]</span></td></tr> | | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1dg0 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1dg0 OCA], [https://pdbe.org/1dg0 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1dg0 RCSB], [https://www.ebi.ac.uk/pdbsum/1dg0 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1dg0 ProSAT]</span></td></tr> |
| </table> | | </table> |
| + | == Function == |
| + | [https://www.uniprot.org/uniprot/COW_CONRA COW_CONRA] Its target is unknown, but this toxin may modulate voltage-activated calcium channels (Cav) or calcium-dependent potassium channels (KCa).[UniProtKB:P0C248][UniProtKB:P0C250][UniProtKB:P62903][UniProtKB:P83047] |
| <div style="background-color:#fffaf0;"> | | <div style="background-color:#fffaf0;"> |
| == Publication Abstract from PubMed == | | == Publication Abstract from PubMed == |
Line 23: |
Line 25: |
| [[Category: Conus radiatus]] | | [[Category: Conus radiatus]] |
| [[Category: Large Structures]] | | [[Category: Large Structures]] |
- | [[Category: He, W]] | + | [[Category: He W]] |
- | [[Category: Jimenez, E C]] | + | [[Category: Jimenez EC]] |
- | [[Category: Norton, R S]] | + | [[Category: Norton RS]] |
- | [[Category: Olivera, B M]] | + | [[Category: Olivera BM]] |
- | [[Category: Pallaghy, P K]] | + | [[Category: Pallaghy PK]] |
- | [[Category: Cis-trans isomerism]]
| + | |
- | [[Category: Contryphan]]
| + | |
- | [[Category: Cyclic peptide]]
| + | |
- | [[Category: D-tryptophan]]
| + | |
- | [[Category: Disulfide bridge]]
| + | |
- | [[Category: Toxin]]
| + | |
| Structural highlights
Function
COW_CONRA Its target is unknown, but this toxin may modulate voltage-activated calcium channels (Cav) or calcium-dependent potassium channels (KCa).[UniProtKB:P0C248][UniProtKB:P0C250][UniProtKB:P62903][UniProtKB:P83047]
Publication Abstract from PubMed
The contryphan family of cyclic peptides, isolated recently from various species of cone shell, has the conserved sequence motif NH(3)(+)-X(1)COD-WX(5)PWC-NH(2), where X(1) is either Gly or absent, O is 4-trans-hydroxyproline, and X(5) is Glu, Asp, or Gln. The solution structures described herein of two new naturally occurring contryphan sequences, contryphan-Sm and des[Gly1]-contryphan-R, are similar to those of contryphan-R, the structure of which has been determined recently [Pallaghy et al. (1999) Biochemistry 38, 11553-11559]. The (1)H NMR chemical shifts of another naturally occurring peptide, contryphan-P, indicate that it also adopts a similar structure. All of these contryphans exist in solution as a mixture of two conformers due to cis-trans isomerization about the Cys2-Hyp3 peptide bond. The lower cis-trans ratio for contryphan-Sm enabled elucidation of the 3D structure of both its major and its minor forms, for which the patterns of (3)J(H)(alpha)(HN) coupling constants are very different. As with contryphan-R, the structure of the major form of contryphan-Sm (cis Cys2-Hyp3 peptide bond) contains an N-terminal chain reversal and a C-terminal type I beta-turn. The minor conformer (trans peptide bond) forms a hairpin structure with sheetlike hydrogen bonds and a type II beta-turn, with the D-Trp4 at the 'Gly position' of the turn. The ratio of conformers arising from cis-trans isomerism around the peptide bond preceding Hyp3 is sensitive to both the amino acid sequence and the solution conditions, varying from 2.7:1 to 17:1 across the five sequences. The sequence and structural determinants of the cis-trans isomerism have been elucidated by comparison of the cis-trans ratios for these peptides with those for contryphan-R and an N-acetylated derivative thereof. The cis-trans ratio is reduced for peptides in which either the charged N-terminal ammonium or the X(5) side-chain carboxylate is neutralized, implying that an electrostatic interaction between these groups stabilizes the cis conformer relative to the trans. These results on the structures and cis-trans equilibrium of different conformers suggest a paradigm of 'locally determined but globally selected' folding for cyclic peptides and constrained protein loops, where the series of stereochemical centers in the loop dictates the favorable conformations and the equilibrium is determined by a small number of side-chain interactions.
Structures of the contryphan family of cyclic peptides. Role of electrostatic interactions in cis-trans isomerism.,Pallaghy PK, He W, Jimenez EC, Olivera BM, Norton RS Biochemistry. 2000 Oct 24;39(42):12845-52. PMID:11041849[1]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
References
- ↑ Pallaghy PK, He W, Jimenez EC, Olivera BM, Norton RS. Structures of the contryphan family of cyclic peptides. Role of electrostatic interactions in cis-trans isomerism. Biochemistry. 2000 Oct 24;39(42):12845-52. PMID:11041849
|